Tishman Speyer, Bellco Capital JV raises $3B for life science buys

Breakthrough Properties fund will finance existing developments, new buys

Los Angeles /
Apr.April 29, 2022 01:58 PM
Breakthrough Properties’ Dan Belldegrun, Tishman’s Rob Speyer and Bellco Capital’s Rebecka Belldegrun (Breakthrough Properties, Tishman, Bellco Capital)
Breakthrough Properties’ Dan Belldegrun, Tishman’s Rob Speyer and Bellco Capital’s Rebecka Belldegrun (Breakthrough Properties, Tishman, Bellco Capital)

A joint venture between Tishman Speyer and Los Angeles-based biopharmaceutical investment firm Bellco Capital has raised $3 billion to develop and buy life science properties across the U.S. and Europe.

The limited partnership, dubbed Breakthrough Properties, raised the funds from “institutional investors, sovereign wealth funds and high net worth individuals.” Breakthrough had initially aimed to raise $1.5 billion, when it opened the fund in 2020.

With the new funding, Breakthrough could spend up to $6 billion on development and acquisitions, according to the Financial Times.

“There is an acute and accelerating need for well-located, cutting-edge lab space,” Tishman Speyer CEO Rob Speyer said in a statement.

National average asking rents for lab, research and development space hit $67.05 per square foot annually in the fourth quarter of 2021 — a 7.8 percent jump compared to the prior three months, according to CBRE.

Demand for space is being driven by an acceleration in venture capital funding for life sciences technology and businesses. Since 2016, VC funding for life sciences has grown more than 320 percent to more than $8 billion in the fourth quarter of 2021.

Breakthrough is currently focused on a few core life science markets in the U.S. — Boston, San Diego and Philadelphia — along with Amsterdam and the United Kingdom.

In Boston, the firm is building a 263,500-square-foot property that is fully leased to CRISPR Therapeutics, a public biotech firm. Across the country in San Diego, Breakthrough is developing a 515,000-square-foot research and development campus, part of which is pre-leased to medical tech firm BD.





    Related Articles

    arrow_forward_ios
    Pasadena Mayor Victor Gordo with the 710 stub (City of Pasadena, Google Maps)
    Returned 710 Freeway parcel in Pasadena apt for development
    Returned 710 Freeway parcel in Pasadena apt for development
    Queen Mary (Google Maps, iStock)
    Long Beach to size up Queen Mary in wake of failed redevelopment plan
    Long Beach to size up Queen Mary in wake of failed redevelopment plan
    Prologis' Hamid Moghadam and 8819 E Edison Ave in Ontario (Google Maps, Prologis)
    Prologis gets option on 177 more acres in Ontario Ranch
    Prologis gets option on 177 more acres in Ontario Ranch
    Assembly Majority Leader Eloise Gómez Reyes (47th Assembly District, iStock)
    Inland Empire industrial developers dodge a bullet — for now
    Inland Empire industrial developers dodge a bullet — for now
    SRG's Chris Payne and Burnham Ward's Bryon Ward with rendering of New Laguna Niguel City Center (Sares Regis Group, Burnham Ward Properties)
    ‘Napa Valley-esque’ downtown to be built in Laguna Niguel
    ‘Napa Valley-esque’ downtown to be built in Laguna Niguel
    LaTerra Development's Charles Tourtellotte with 4112 Del Rey Avenue (LinkedIn, Loopnet)
    LaTerra buys Marina del Rey office complex
    LaTerra buys Marina del Rey office complex
    CIM’s Shaul Kuba with renderings of the project at 6007 Sunset Blvd in Hollywood (Getty, CIM Group)
    CIM sells site of 109-unit resi development in Hollywood
    CIM sells site of 109-unit resi development in Hollywood
    FS Investments' Michael Forman and Tishman Speyer's Rob Speyer with 555 South Aviation Boulevard (Tishman Speyer, LoopNet, iStock)
    Tishman Speyer notches priciest LA office sale of year
    Tishman Speyer notches priciest LA office sale of year
    arrow_forward_ios

    The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

    Loading...